This announcement is a separate document:
科伦药业：关于子公司创新药物注射用SKB518新药临床试验申请获国家药品监督管理局批准的公告
Sichuan Kelun Pharmaceutical: Announcement on the approval of the clinical trial application of pharmaceutical injection SKB518 for innovative drugs of a subsidiary by the National Medical Products Administration.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated